Aravt Global’s Elanco Animal Health ELAN Stock Holding History

Aravt Global’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,000	Closed	-$631K	–	16
2018 Q4	$631K	Hold	20,000	–	–	0.09%	15
2018 Q3	$698K	Buy	+20,000	New	+$703K	0.09%	11

Other funds holding ELAN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Aravt Global's ELAN Position: Q1 2019 in Review

Aravt Global sold out of Elanco Animal Health (ELAN) in Q1 2019, closing a stake of 20,000 shares — an estimated $631K sold.

Aravt Global first reported a position in ELAN in Q3 2018 and held it in 2 quarters. The position peaked at $698K in Q3 2018. 344 funds tracked by Wall St. Rank hold ELAN as of Q1 2019.

Aravt Global reported no remaining Elanco Animal Health position as of Q1 2019 after selling out during the quarter.
Aravt Global sold 20,000 Elanco Animal Health shares in Q1 2019, an estimated $631K.
Aravt Global first reported a position in Elanco Animal Health in Q3 2018 and held it in 2 quarters.
Aravt Global's Elanco Animal Health position peaked at $698K in Q3 2018.
344 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2019.

Based on Aravt Global's 13F filing for Q1 2019, filed 15 May 2019.